Emerging Longevity Ventures is a venture capital fund that invests in early-stage companies within the health tech and biotech sectors. They support the development of new technologies and treatments, providing financial backing with checks ranging from $500,000 to $5 million. A notable investment is Senisca, a company focused on reversing cellular aging.
